Review on COVID-19 biomedical waste-derived microplastic toxicity

Australia News News

Review on COVID-19 biomedical waste-derived microplastic toxicity
Australia Latest News,Australia Headlines
  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 34 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 71%

Review on COVID-19 biomedical waste-derived microplastic toxicity Microplastics Toxicity COVID19 SARSCoV2 BiomedicalWaste

By Pooja Toshniwal PahariaOct 11 2022Reviewed by Aimee Molineux In a recent review published in Environmental Research, researchers reviewed existing literature on the biomedical waste source, elements, and the recent upsurge of microplastics during the severe acute respiratory syndrome coronavirus 2 pandemic, as well as MP accumulation effects on aquatic and terrestrial organisms and human health.

BW sources, elements, and transformation BW during COVID-19 comprises PPE equipment , pharmaceutical waste and general waste . Air may contain pathogenic bacteria, dioxin and furan , particulate matter, metals, acid gases, oxides of nitrogen, and sulfur. The polymers eventually convert into MP monomers by biological , or non-biological processes.

Health implications and biomarkers of MP accumulation in humans MPs pose a severe threat to human health. MPs could enter the human body indirectly from terrestrial and aquatic organisms and accumulate in human tissues, leading to reactive oxygen species generation and increased oxidative stress.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NewsMedical /  🏆 19. in UK

Australia Latest News, Australia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Scientists explore kinetics of naturally induced anti-SARS-CoV-2 antibodies in the Kenyan populationScientists explore kinetics of naturally induced anti-SARS-CoV-2 antibodies in the Kenyan populationIn a new study, researchers investigated the breadth and longevity of immunity induced by natural severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exposure among the Kenyan population.
Read more »

Researchers explore drug-repurposing candidates acting against nucleotide-binding pockets of multiple SARS-CoV-2 proteinsResearchers explore drug-repurposing candidates acting against nucleotide-binding pockets of multiple SARS-CoV-2 proteinsIn a new study, researchers pursued direct-acting severe acute respiratory syndrome coronavirus-2 drugs that compete for nucleotide-binding pockets (NBPs) of SARS-CoV-2 proteins.
Read more »

Pulmonary radiological patterns in patients diagnosed with SARS-CoV-2 pneumoniaPulmonary radiological patterns in patients diagnosed with SARS-CoV-2 pneumoniaPulmonary radiological patterns in patients diagnosed with SARS-CoV-2 pneumonia UdeGuanajuato pulmonary radiology SARSCoV2 COVID19 coronavirus covid pneumonia
Read more »

What is the association of SARS-CoV-2 vaccination with the risk of PASC in patients with SARDs?What is the association of SARS-CoV-2 vaccination with the risk of PASC in patients with SARDs?Findings of a new study depicted that fully vaccinated patients suffering from systemic autoimmune rheumatic diseases harbor a lower propensity to developing long COVID symptoms compared to SARDs patients who are not fully vaccinated.
Read more »

Timely COVID-19 boosters may prevent care facility outbreaksTimely COVID-19 boosters may prevent care facility outbreaksTimely COVID-19 boosters may prevent care facility outbreaks rivm COVID19 coronavirus covid vaccine vaccination booster
Read more »

RNA-dependent RNA polymerase inhibitors in COVID-19 therapyRNA-dependent RNA polymerase inhibitors in COVID-19 therapyA new paper reviews current knowledge of RdRp inhibitors that could be developed further to provide broadly effective antivirals against SARS-CoV-2 in particular and CoVs in general.
Read more »



Render Time: 2025-04-02 00:25:33